US FDA Greenlights GE HealthCare’s Diagnostic Drug for Heart Disease
The U.S. Food and Drug Administration approved GE HealthCare’s (NASDAQ: GEHC) diagnostic drug for use in the detection of coronary […]
US FDA Greenlights GE HealthCare’s Diagnostic Drug for Heart Disease Read More »
